![Quiver Logo](/static/img/logo-icon.png)
![CEROW logo](https://quiver-logos.s3.us-east-2.amazonaws.com/cerow.png)
CERo Therapeutics Holdings, Inc. Warrants
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CEROW Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of CEROW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CEROW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to CEROW
Recent picks made for CEROW stock on CNBC
ETFs with the largest estimated holdings in CEROW
Flights by private jets registered to CEROW
![Quiver Logo](/static/img/logo-icon.png)